Molecular mechanisms of cisplatin resistance

Galluzzi, L, Senovilla, L, Vitale, I, Michels, J, Martins, I, Kepp, O, Castedo, M, Kroemer, G·2012·Oncogene
DOI 10.1038/onc.2011.384

Cited by (1,001)

Items 801–900 of 1,001

  1. Synthetic Lethality Screening Identifies FDA-Approved Drugs that Overcome ATP7B-Mediated Tolerance of Tumor Cells to Cisplatin
    Marta Mariniello, Raffaella Petruzzelli, Luca G. Wanderlingh, Raffaele La Montagna, Annamaria Carissimo, Francesca Pane, Angela Amoresano, Ekaterina Yu. Ilyechova, Michael M. Galagudza, Federico Catalano et al. · 2020 · Cancers
  2. In-vitro antibacterial, antioxidant and cytotoxic potential of gold nanoparticles synthesized using novel Elaeocarpus ganitrus seeds extract
    S. P. Vinay, Udayabhanu, H.N. Sumedha, M. Shashank, G. Nagaraju, Naisa Chandrasekhar · 2020 · Journal of Science Advanced Materials and Devices
  3. Selective Anti-Cancer Effects of Plasma-Activated Medium and Its High Efficacy with Cisplatin on Hepatocellular Carcinoma with Cancer Stem Cell Characteristics
    Yan Li, Tianyu Tang, Hae June Lee, Kiwon Song · 2021 · International Journal of Molecular Sciences
  4. Evaluation of anticancer effects in vitro of new iridium(III) complexes targeting the mitochondria
    Jing Cheng Hao, Huiwen Zhang, Tian Xiang Li, Linlin Yang, Yi Zhou, Yuanyuan Zhang, Yun‐Jun Liu, De-Gang Xing · 2021 · Journal of Inorganic Biochemistry
  5. Resveratrol Modulation of Apoptosis and Cell Cycle Response to Cisplatin in Head and Neck Cancer Cell Lines
    Marinela Bostan, Mirela Antonela Mihaila, Georgiana Gabriela Petrică-Matei, Nicoleta Radu, Răzvan Hainăroșie, Cristian Dragos Stefanescu, Viviana Roman, Carmen Cristina Diaconu · 2021 · International Journal of Molecular Sciences
  6. Research progress of azido-containing Pt(IV) antitumor compounds
    Meilin Mu, Jiuyu Zhan, Xiaohan Dai, Hongwei Gao · 2021 · European Journal of Medicinal Chemistry
  7. Gynecologic Cancer, Cancer Stem Cells, and Possible Targeted Therapies
    Vahideh Keyvani, Espanta Riahi, Meysam Yousefi, Seyed‐Alireza Esmaeili, Rana Shafabakhsh, Amin Moradi Hasan‐Abad, Maryam Mahjoubin‐Tehran, Michael Richard Hamblin, Samaneh Mollazadeh, Hamed Mirzaei · 2022 · Frontiers in Pharmacology
  8. The cisplatin-based Pt( iv )-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions
    Elisabetta Gabano, Mauro Ravera, Francesca Trivero, Stefano Tinello, Andrea Gallina, Ilaria Zanellato, Marzia Bruna Gariboldi, Elena Monti, Domenico Osella · 2018 · Dalton Transactions
  9. Cisplatin Chemotherapy and Cochlear Damage: Otoprotective and Chemosensitization Properties of Polyphenols
    Anna Rita Fetoni, Fabiola Paciello, Diana Troiani · 2021 · Antioxidants and Redox Signaling
  10. RETRACTED ARTICLE: LncRNA SNHG12 in extracellular vesicles derived from carcinoma-associated fibroblasts promotes cisplatin resistance in non-small cell lung cancer cells
    Deli Tan, Gang Li, Peng Zhang, Chao Peng, Bo He · 2022 · Bioengineered · Retracted
  11. Trial Watch
    Fernando Aranda, Erika Vacchelli, Florine Obrist, Alexander M.M. Eggermont, Jérôme Galon, Wolf H. Fridman, Isabelle Cremer, Éric Tartour, Laurence Zitvogel, Guido Kroemer et al. · 2014 · OncoImmunology
  12. M2 tumor-associated macrophage mediates the maintenance of stemness to promote cisplatin resistance by secreting TGF-β1 in esophageal squamous cell carcinoma
    Kaige Yang, Yufang Xie, Lele Xue, Fanping Li, Chenghua Luo, Weihua Liang, Haijun Zhang, Ya Li, Yilin Ren, Mengmeng Zhao et al. · 2023 · Journal of Translational Medicine
  13. Research Progress of Plant-Derived Natural Products against Drug-Resistant Cancer
    Wenli Liu, Yuqin Wang, Lijie Xia, Jinyao Li · 2024 · Nutrients
  14. Targeting Hsp90 in urothelial carcinoma
    Mahmoud Chehab, Tiffany N. Caza, Kamil Skotnicki, STEVE K. LANDAS, Gennady Bratslavsky, Mehdi Mollapour, Dimitra Bourboulia · 2015 · Oncotarget
  15. DKK1 is a potential novel mediator of cisplatin-refractoriness in non-small cell lung cancer cell lines
    Hogir Salim, Dali Zong, Petra Hååg, Metka Novak, Birgitta Mörk, Rolf Lewensohn, Lovisa Lundholm, Kristina Viktorsson · 2015 · BMC Cancer
  16. A novel role for the anti-senescence factor TBX2 in DNA repair and cisplatin resistance
    Sabina Maria Wansleben, Emily F. Davis-Marcisak, Jade Peres, Sharon Prince · 2013 · Cell Death and Disease
  17. Systems Biology Approach Identifies the Kinase Csnk1a1 as a Regulator of the DNA Damage Response in Embryonic Stem Cells
    Jordi Carreras Puigvert, Louise von Stechow, Ramakrishnaiah Siddappa, Alex Pines, Mahnoush Bahjat, Lizette C. J. M. Haazen, Jesper V. Olsen, Harry Vrieling, John H.N. Meerman, Leon H.F. Mullenders et al. · 2013 · Science Signaling
  18. SKA1 regulates the metastasis and cisplatin resistance of non-small cell lung cancer
    Lihua Shen, Min Yang, Qionghua Lin, Zhongwei Zhang, Changhong Miao, Biao Zhu · 2016 · Oncology Reports
  19. A Comprehensive Review on the Genetic Regulation of Cisplatin-induced Nephrotoxicity
    Zeneida Herrera Pérez, Norbert Gretz, Harsh Dweep · 2016 · Current Genomics
  20. Role of Wnt/β-catenin, Wnt/c-Jun N-terminal kinase and Wnt/Ca2+ pathways in cisplatin-induced chemoresistance in ovarian cancer
    Lu Hsiang Huang, Ye Jin, Shujun Feng, Yuqing Zou, Sainan Xu, Shuang Qiu, Ling Li, Jianhua Zheng · 2016 · Experimental and Therapeutic Medicine
  21. A feasibility study for enrichment of highly aggressive cancer subpopulations by their biophysical properties via dielectrophoresis enhanced with synergistic fluid flow
    Temple Anne Douglas, Jaka Čemažar, Nikita Balani, Daniel C. Sweeney, Eva M. Schmelz, Rafael V. Davalos · 2017 · Electrophoresis
  22. The dynamic role of autophagy and MAPK signaling in determining cell fate under cisplatin stress in osteosarcoma cells
    Sudeshna Mukherjee, Subhra Dash, K. Lohitesh, Rajdeep Chowdhury · 2017 · PLoS ONE
  23. ER-α36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway
    Linlin Zhu, Jiao Zou, Yuanyin Zhao, Xiaomei Jiang, Yang Wang, Xiangwei Wang, Bin Chen · 2018 · Journal of Experimental & Clinical Cancer Research
  24. Association between genetic polymorphisms and platinum-induced ototoxicity in children
    Gabrielle Lui, the SFCE (Société Française des Cancers de l’Enfant et l’Adolescent), Naïm Bouazza, Françoise Denoyelle, Marion Moine, Laurence Brugières, Pascal B. Chastagner, Nadège Corradini, Natacha Entz‐Werlé, Cécile Verite et al. · 2018 · Oncotarget
  25. Lenvatinib-zinc phthalocyanine conjugates as potential agents for enhancing synergistic therapy of multidrug-resistant cancer by glutathione depletion
    Gaofei Wei, Liang‐Feng Huang, Yali Jiang, Yifeng Shen, Zeqian Huang, Yanjuan Huang, Xiaoqi Sun, Chunshun Zhao · 2019 · European Journal of Medicinal Chemistry
  26. Targeting V-ATPase Isoform Restores Cisplatin Activity in Resistant Ovarian Cancer: Inhibition of Autophagy, Endosome Function, and ERK/MEK Pathway
    Arpita Kulshrestha, Gajendra Kumar Katara, Safaa Abdel-Salam Ibrahim, Valerie E. Riehl, Manoranjan Sahoo, James Dolan, Kyle W. Meinke, Michael R. Pins, Kenneth D. Beaman · 2019 · Journal of Oncology
  27. Synthesis and Anticancer Activity of Gold Porphyrin Linked to Malonate Diamine Platinum Complexes
    Isabelle Toubia, Christophe Nguyen, Stéphane Diring, Lamiaa M. A. Ali, Ludivine Larue, Rabab Aoun, Céline Frochot, Magali Gary‐Bobo, Marwan Kobeissi, Fabrice Odobel · 2019 · Inorganic Chemistry
  28. Combination of Decitabine and Entinostat Synergistically Inhibits Urothelial Bladder Cancer Cells via Activation of FoxO1
    Chenyin Wang, Alexandra Hamacher, Patrick Petzsch, Karl Köhrer, Günter Niegisch, Michèle J. Hoffmann, Wolfgang A. Schulz, Matthias Ulrich Kassack · 2020 · Cancers
  29. MiR-29b-3p Reverses Cisplatin Resistance by Targeting COL1A1 in Non-Small-Cell Lung Cancer A549/DDP Cells
    Rui Jia, Changli Wang · 2020 · Cancer Management and Research
  30. Sequential Interferon β-Cisplatin Treatment Enhances the Surface Exposure of Calreticulin in Cancer Cells via an Interferon Regulatory Factor 1-Dependent Manner
    Pei‐Ming Yang, Yao‐Yu Hsieh, Jia-Ling Du, Shih-Chieh Yen, Chien‐Fu Hung · 2020 · Biomolecules
  31. MicroRNA-1291-5p Sensitizes Pancreatic Carcinoma Cells to Arginine Deprivation and Chemotherapy through the Regulation of Arginolysis and Glycolysis
    Mei‐Juan Tu, Zhijian Duan, Zhenzhen Liu, Chao Zhang, Richard J. Bold, Frank J. Gonzalez, Edward Jae-Hoon Kim, Ai‐Ming Yu · 2020 · Molecular Pharmacology
  32. A Cisplatin‐Selective Fluorescent Probe for Real‐Time Monitoring of Mitochondrial Platinum Accumulation in Living Cells
    Jun Xiang Ong, Hai Van Le, Violet Eng Yee Lee, Wee Han Ang · 2020 · Angewandte Chemie International Edition
  33. Why Concurrent CDDP and Radiotherapy Has Synergistic Antitumor Effects: A Review of In Vitro Experimental and Clinical-Based Studies
    Shinsuke Nagasawa, Junko Takahashi, Gen Suzuki, Hideya Yamazaki, Kei Yamada · 2021 · International Journal of Molecular Sciences
  34. TTN/TP53 mutation might act as the predictor for chemotherapy response in lung adenocarcinoma and lung squamous carcinoma patients
    Dan Xue, Hongguang Lin, Lan Lin, Qiongying Wei, Sheng Yang, Xiangqi Chen · 2021 · Translational Cancer Research
  35. Let‐7i miRNA and platinum loaded nano‐graphene oxide platform for detection/reversion of drug resistance and synergetic chemical‐photothermal inhibition of cancer cell
    Jianhua Yan, Yixuan Zhang, Lijuan Zheng, Yuwei Wu, Ting Wang, Ting Jiang, Xiaoqin Liu, Dongming Peng, Yanfei Liu, Zhenbao Liu · 2021 · Chinese Chemical Letters
  36. Long non-coding RNA MEG3 promotes cisplatin-induced nephrotoxicity through regulating AKT/TSC/mTOR-mediated autophagy
    Jing Xu, Jinming Han, Junhao Zhang, Yi Chen, Juan Yuan, Jue Wang, Shiyong Neo, Shuijie Li, Xueyuan Yu, Jing Wu · 2021 · International Journal of Biological Sciences
  37. MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin
    Maria Yurievna Konoshenko, Yuriy Lansukhay, Sergey E. Krasilnikov, Pavel Petrovich Laktionov · 2022 · International Journal of Molecular Sciences
  38. PKA/Smurf1 signaling-mediated stabilization of Nur77 is required for anticancer drug cisplatin-induced apoptosis
    Haishan Lin, Qi Lin, Min Liu, Yong Lin, X Wang, H Chen, Zongping Xia, Binfeng Lu, F Ding, Q Wu et al. · 2013 · Oncogene
  39. Antitumor Effects of a Novel Small Molecule Targeting PCNA Chromatin Association in Prostate Cancer
    Kelsey Dillehay McKillip, Shan Lu, Zhongyun Dong · 2014 · Molecular Cancer Therapeutics
  40. Long non-coding RNA AK001796 contributes to cisplatin resistance of non-small cell lung cancer
    Bin Liu, Chunfeng Pan, Teng Ma, Jun Wang, Guoliang Yao, Ke Wei, Yijiang Chen · 2017 · Molecular Medicine Reports
  41. The effectiveness of eugenol against cisplatin-induced ototoxicity
    Muhammed Sedat Sakat, Korhan Kılıç, Fazile Nur Eki̇nci̇ Akdemi̇r, Serkan Yıldırım, Gizem Eser, Ahmet Kızıltunç · 2018 · Brazilian Journal of Otorhinolaryngology
  42. Anti-apoptotic effect of clusterin on cisplatin-induced cell death of retinoblastoma cells
    Hyun Beom Song, Hyoung-Oh Jun, Jin Hyoung Kim, Young Suk Yu, Kyu-Won Kim, Bon-Hong Min, Jeong Hun Kim · 2013 · Oncology Reports
  43. Osteoclast Cancer Cell Metabolic Cross-talk Confers PARP Inhibitor Resistance in Bone Metastatic Breast Cancer
    Huijuan Fan, Zhanao Xu, Ke Yao, Bingxin Zheng, Yuan Zhang, Xuxiang Wang, Tengjiang Zhang, Xuan Li, Haitian Hu, Bin Yue et al. · 2023 · Cancer Research
  44. Defects of mitochondria-lysosomes communication induce secretion of mitochondria-derived vesicles and drive chemoresistance in ovarian cancer cells
    Sinforosa Gagliardi, Marco Mitruccio, Riccardo Di Corato, Roberta Romanò, Alessandra Aloisi, Rosaria Rinaldi, Pietro Alifano, Flora Guerra, Cecilia Bucci · 2024 · Cell Communication and Signaling
  45. Cisplatin-based combination therapies: Their efficacy with a focus on ginsenosides co-administration
    Keke Li, Jiwen Li, Zhongyu Li, Lei Men, Haibin Zuo, Xiao‐Jie Gong · 2024 · Pharmacological Research
  46. Trans‐Platinum/Thiazole Complex Interferes with Sp1 Zinc‐Finger Protein
    Siming Chen, Dechen Xu, Huan Jiang, Zhaoyong Xi, Pingping Zhu, Yangzhong Liu · 2012 · Angewandte Chemie International Edition
  47. Induction of Autophagic Death in Cancer Cells by Agonizing TR3 and Attenuating Akt2 Activity
    Wei-jia Wang, Yuan Wang, Pei-pei Hou, Feng-wei Li, Bo Zhou, Hang‐zi Chen, Xueli Bian, Qixu Cai, Yong-zhen Xing, Jianping He et al. · 2015 · Chemistry & Biology
  48. ATR-Chk1 signaling inhibition as a therapeutic strategy to enhance cisplatin chemosensitivity in urothelial bladder cancer
    Ching‐Chia Li, Juan‐Cheng Yang, Mei‐Chin Lu, Chia-Lin Lee, Chieh-Yu Peng, Wei-Yu Hsu, Yun-Hao Dai, Fang‐Rong Chang, Da-yong Zhang, Wen‐Jeng Wu et al. · 2015 · Oncotarget
  49. Chromatin Regulates Genome Targeting with Cisplatin
    Emmanouil Zacharioudakis, Poonam Agarwal, Alexandra Bartoli, Nathan S. Abell, Lavaniya Kunalingam, Valérie Bergoglio, Blerta Xhemalçe, Kyle M. Miller, Raphaël Rodriguez · 2017 · Angewandte Chemie International Edition
  50. JNK-AKT-NF-κB controls P-glycoprotein expression to attenuate the cytotoxicity of deoxynivalenol in mammalian cells
    Xiaoming Li, Peiqiang Mu, Han Qiao, Jikai Wen, Yiqun Deng · 2018 · Biochemical Pharmacology
  51. XPA, XPC, and XPD Modulate Sensitivity in Gastric Cisplatin Resistance Cancer Cells
    Natalia Pajuelo‐Lozano, Jone Bargiela-Iparraguirre, Gemma Domínguez, Adoración G. Quiroga, Rosario Perona, Isabel Sánchez‐Pérez · 2018 · Frontiers in Pharmacology
  52. Graviola leaves extract enhances the anticancer effect of cisplatin on various cancer cell lines
    Mai G. Awad, Ramadan A. Ali, Dalia Demerdash Abd El Monem Hafez, Mohammed A. El‐Magd · 2020 · Molecular & Cellular Toxicology
  53. The Synergistic Anticancer Effect of Dual Drug- (Cisplatin/Epigallocatechin Gallate) Loaded Gelatin Nanoparticles for Lung Cancer Treatment
    Yin‐Ju Chen, Zhi-Weng Wang, Tung-Ling Lu, Clinton B. Gomez, Hsu-Wei Fang, Yang Wei, Ching‐Li Tseng · 2020 · Journal of Nanomaterials
  54. The Role of Plasma Membrane Viscosity in the Response and Resistance of Cancer Cells to Oxaliplatin
    Liubov E. Shimolina, Alexander A. Gulin, Nadezhda I. Ignatova, Дружкова Ирина Николаевна, Margarita V. Gubina, Maria M. Lukina, Ludmila B. Snopova, Загайнова Елена Вадимовна, Marina K. Kuimova, Marina V. Shirmanova · 2021 · Cancers
  55. Targeting YAP1 / TAZ in nonsmall‐cell lung carcinoma: From molecular mechanisms to precision medicine
    Chun Wai Mui, Wai Nok Chan, Bonan Chen, Alvin H.K. Cheung, Jun Qing Yu, Kwok Wai Lo, Ke Huixing, Wei Kang, Ka Fai To · 2022 · International Journal of Cancer
  56. Synthesis, Characterization and Crystal Structure of Organotin(IV) N-Butyl-N-Phenyldithiocarbamate Compounds and their Cytotoxicity in Human Leukemia Cell Lines
    Nurul Farahana Kamaludin, Normah Awang, Ibrahim Baba, Asmah Hamid, Chan Kok Meng · 2012 · Pakistan Journal of Biological Sciences
  57. Complex Structures Made Simple – Continuous Flow Production of Core Cross‐Linked Polymeric Micelles for Paclitaxel Pro‐Drug‐Delivery
    Tobias Alexander Bauer, Jonas Schramm, Federico Fenaroli, Svenja Siemer, Christine Ilona Seidl, Christine Rosenauer, Regina Bleul, Roland H. Stauber, Kaloian Koynov, Michael Maskos et al. · 2023 · Advanced Materials
  58. Cancer Mutations Converge on a Collection of Protein Assemblies to Predict Resistance to Replication Stress
    Xiaoyu Zhao, Akshat Singhal, Sungjoon Park, JungHo Kong, Robin E. Bachelder, Trey E. Ideker · 2024 · Cancer Discovery
  59. From computational modelling of the intrinsic apoptosis pathway to a systems-based analysis of chemotherapy resistance: achievements, perspectives and challenges in systems medicine
    Maximilian L. Würstle, Elisabeth Zink, Jochen H.M. Prehn, Markus Rehm · 2014 · Cell Death and Disease
  60. Independent transcriptional reprogramming and apoptosis induction by cisplatin
    Lorenzo Galluzzi, Ilio Vitale, Laura Senovilla, Tobias Eisenberg, Didac Carmona‐Gutiérrez, Erika Vacchelli, Thomas Robert, Hugues Ripoche, Nora Jägemann, Caroline Paccard et al. · 2012 · Cell Cycle
  61. Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells
    Michaela L. Granados, Laurie G. Hudson, Sabrina L. Samudio‐Ruiz · 2015 · PLoS ONE
  62. Yu Ping Feng San reverses cisplatin-induced multi-drug resistance in lung cancer cells via regulating drug transporters and p62/TRAF6 signalling
    Jian-Shu Lou, Artemis Lu Yan, Cathy W. C. Bi, Gallant Kar-Lun Chan, Qiyun Wu, Yun-Le Liu, Yun Huang, Ping Yao, Crystal Y. Q. Du, Tina Ting-Xia Dong et al. · 2016 · Scientific Reports
  63. Immunomodulatory proteins FIP-gts and chloroquine induce caspase-independent cell death via autophagy for resensitizing cisplatin-resistant urothelial cancer cells
    I‐Lun Hsin, Shao‐Chuan Wang, Jian‐Ri Li, Tsai-Chun Ciou, Chih‐Hsien Wu, Hung‐Ming Wu, Jiunn‐Liang Ko · 2016 · Phytomedicine
  64. Morpholine hydrazone scaffold: Synthesis, anticancer activity and docking studies
    Muhammad Taha, Syed Adnan Alı Shah, Muhammad Afifi, Manar Zulkeflee, Sadia Sultan, Abdul Wadood, Fazal Rahim, Nor Hadiani Ismail · 2016 · Chinese Chemical Letters
  65. Role of endoplasmic reticulum stress on cisplatin resistance in ovarian carcinoma
    Jing Tian, Rong Liu, Quanxin Qu · 2017 · Oncology Letters
  66. Hyper-phosphorylation of Sequestosome-1 Distinguishes Resistance to Cisplatin in Patient Derived High Grade Serous Ovarian Cancer Cells
    Elizabeth V. Nguyen, Kaisa Huhtinen, Young Ah Goo, Katja Kaipio, Noora Andersson, Ville Rantanen, Johanna Hynninen, Riitta Lahesmaa, Olli Carpén, David R. Goodlett · 2017 · Molecular & Cellular Proteomics
  67. Pt(IV)-based nanoscale coordination polymers: Antitumor activity, cellular uptake and interactions with nuclear DNA
    N.N. Adarsh, Carolina Frias, T.M. Ponnoth Lohidakshan, Júlia Lorenzo, Fernando Novio, Javier García‐Pardo, Daniel Ruiz‐Molina · 2018 · Chemical Engineering Journal
  68. S1PR1 predicts patient survival and promotes chemotherapy drug resistance in gastric cancer cells through STAT3 constitutive activation
    Shiyu Song, Haiyan Min, Mengyuan Niu, Lei Wang, Yongzheng Wu, Bin Zhang, Xiufang Chen, Qiao Liang, Yanting Wen, Yong Wang et al. · 2018 · EBioMedicine
  69. Butoxy Mansonone G Inhibits STAT3 and Akt Signaling Pathways in Non-Small Cell Lung Cancers: Combined Experimental and Theoretical Investigations
    Panupong Mahalapbutr, Piyanuch Wonganan, Warinthorn Chavasiri, Thanyada Rungrotmongkol · 2019 · Cancers
  70. Surface Coordination of Black Phosphorus with Modified Cisplatin
    Jianing Zhang, Yue Ma, Kuan Hu, Yuan Ping Feng, Si Chen, Xiaoyang Yang, Jacky Fong-Chuen Loo, Han Zhang, Feng Yin, Zigang Li · 2019 · Bioconjugate Chemistry
  71. Investigation of multicellular tumor spheroids enriched for a cancer stem cell phenotype
    Tetiana Herheliuk, Olena M. Perepelytsina, Andriy P. Ugnivenko, Л. І. Остапченко, Mykhailo Sydorenko · 2019 · Stem Cell Investigation
  72. Knockdown Of lncRNA NCK-AS1 Regulates Cisplatin Resistance Through Modulating miR-137 In Osteosarcoma Cells
    Yi Cheng, Xiaofei Shen, Minqian Zheng, Guoyou Zou, Yixin Shen · 2019 · OncoTargets and Therapy
  73. Circ_0000079 Decoys the RNA-Binding Protein FXR1 to Interrupt Formation of the FXR1/PRCKI Complex and Decline Their Mediated Cell Invasion and Drug Resistance in NSCLC
    Chen Chen, Min Zhang, Yan Zhang · 2020 · Cell Transplantation
  74. PDK2 leads to cisplatin resistance through suppression of mitochondrial function in ovarian clear cell carcinoma
    Sachiko Kitamura, Ken D Yamaguchi, Ryusuke Murakami, Yoko Furutake, Koichiro Higasa, Kaoru Abiko, Junzo Hamanishi, Tsukasa Baba, Noriomi Matsumura, Masaki Mandai · 2021 · Cancer Science
  75. Cisplatin-loaded nanoformulations for cancer therapy: A comprehensive review
    Mehrab Pourmadadi, Mohammad Mahdi Eshaghi, Erfan Rahmani, Narges Ajalli, Shohreh Bakhshi, Helia Mirkhaef, Maryam Vahdat Lasemi, Abbas Rahdar, Razieh Behzadmehr, Ana Maria Diez-Pascual · 2022 · Journal of Drug Delivery Science and Technology
  76. Knock-down of NDRG2 sensitizes cervical cancer Hela cells to cisplatin through suppressing Bcl-2 expression
    Junye Liu, Le Yang, Jiän Zhang, Jing Zhang, Yongbin Chen, Kangchu Li, Yurong Li, Yan Li, Libo Yao, Guozhen Guo · 2012 · BMC Cancer
  77. Resistance to glucose starvation as metabolic trait of platinum-resistant human epithelial ovarian cancer cells
    Anna Pastò, Anna Pagotto, Giorgia Pilotto, Angela De Paoli, Gian Luca De Salvo, Alessandra Baldoni, Maria Ornella Nicoletto, Francesca Ricci, Giovanna L.M. Damia, Chiara Bellio et al. · 2016 · Oncotarget
  78. JWA regulates TRAIL-induced apoptosis via MARCH8-mediated DR4 ubiquitination in cisplatin-resistant gastric cancer cells
    Qiang Wang, Qi Chen, Lei Zhu, M Chen, Wenxia Xu, Sudip Panday, Zhangding Wang, Ao Li, Oluf Dimitri Røe, R Chen et al. · 2017 · Oncogenesis
  79. Theaflavin-3,3′-Digallate Enhances the Inhibitory Effect of Cisplatin by Regulating the Copper Transporter 1 and Glutathione in Human Ovarian Cancer Cells
    Haibo Pan, Eunhye Kim, Gary O'Neal Rankin, Yon Rojanasakul, Youying Tu, Yi Chen · 2018 · International Journal of Molecular Sciences
  80. Quantification of cellular viability by automated microscopy and flow cytometry
    Allan Sauvat, Yidan Wang, Florian Segura, Sabrina Spaggiari, Kévin Müller, Heng Zhou, Lorenzo Galluzzi, Oliver Kepp, Guido Kroemer · 2015 · Oncotarget
  81. Platination of the copper transporter ATP7A involved in anticancer drug resistance
    Vania Calandrini, Fabio Arnesano, Angela Galliani, Trung Hai Nguyen, Emiliano Ippoliti, Paolo Carloni, Giovanni Natile · 2014 · Dalton Transactions
  82. Multifunctional Fe 2 O 3 @PPy-PEG nanocomposite for combination cancer therapy with MR imaging
    Jun Zhou, Jinghua Li, Xingwei Ding, Junjie Liu, Zhong Yuan Luo, Yun Liu, Qichun Ran, Kaiyong Cai · 2015 · Nanotechnology
  83. Trial Watch: Adoptive cell transfer for oncological indications
    Fernando Aranda, Aitziber Buqué, Norma Bloy, Francesca Castoldi, Alexander M.M. Eggermont, Isabelle Cremer, Wolf H. Fridman, Jitka Palich Fucikova, Jérôme Galon, Radek Špíšek et al. · 2015 · OncoImmunology
  84. Combining multi‐dimensional data to identify a key signature (gene and miRNA) of cisplatin‐resistant gastric cancer
    Danyang Zhou, Xing Li, Hengyu Zhao, Banghao Sun, Anqi Liu, Xue Han, Zhongqi Cui, Lijie Yuan · 2018 · Journal of Cellular Biochemistry
  85. Antitumor Platinium(IV) Prodrugs: A Systematic Computational Exploration of Their Reduction Mechanism by l -Ascorbic Acid
    Eslam Dabbish, Fortuna Ponte, Nino Russo, Emilia Sicilia · 2019 · Inorganic Chemistry
  86. Small-Molecule Inhibition of UBE2T/FANCL-Mediated Ubiquitylation in the Fanconi Anemia Pathway
    Matthew Cornwell, Graeme Thomson, Julia Coates, Rimma Belotserkovskaya, Ian D. Waddell, Stephen P. Jackson, Yaron Galanty · 2019 · ACS Chemical Biology
  87. LncRNA MIR4435-2HG mediates cisplatin resistance in HCT116 cells by regulating Nrf2 and HO-1
    Ping Luo, Shugui Wu, ChaoMing Zhou, Xia Yuan, Hongmi Li, Jinping Chen, Yunfei Tian, Yang Qiu, Xiaoming Zhong · 2020 · PLoS ONE
  88. MUTYH as an Emerging Predictive Biomarker in Ovarian Cancer
    Megan L. Hutchcraft, Holly H. Gallion, Jill Kolesar · 2021 · Diagnostics
  89. Inhibition of Bruton’s tyrosine kinase as a therapeutic strategy for chemoresistant oral squamous cell carcinoma and potential suppression of cancer stemness
    Shao‐Cheng Liu, Yang‐Che Wu, Chih-Ming Huang, Ming‐Shou Hsieh, Ting-Yi Huang, Chin-Sheng Huang, Tung-Nien Hsu, Mao-Suan Huang, Wei‐Hwa Lee, Chi‐Tai Yeh et al. · 2021 · Oncogenesis
  90. Targeting protein–protein interactions in the DNA damage response pathways for cancer chemotherapy
    Kerry Silva McPherson, Dmitry M. Korzhnev · 2021 · RSC Chemical Biology
  91. Comparative NMR metabolomics of the responses of A2780 human ovarian cancer cells to clinically established Pt-based drugs
    Veronica Ghini, Francesca Magherini, Lara Massai, Luigi Messori A, Paola Turano · 2022 · Dalton Transactions
  92. Amlexanox-Modified Platinum(IV) Complex Triggers Apoptotic and Autophagic Bimodal Death of Cancer Cells
    Yan Guo, Suxing Jin, Dongfan Song, Tao Yang, Jiyong Hu, Xiaowei Hu, Qingqing Han, Jin’an Zhao, Zijian Guo, Xiaoyong Wang · 2022 · European Journal of Medicinal Chemistry
  93. Holographically Activatable Nanoprobe via Glutathione/Albumin‐Mediated Exponential Signal Amplification for High‐Contrast Tumor Imaging
    Ting Li, Shuangxiu Tan, Mengjuan Li, Jie Luo, Yueyue Zhang, Zhen Jiang, Yibin Deng, Liang Han, Hengte Ke, Junkang Shen et al. · 2022 · Advanced Materials
  94. pH-responsive delivery of Platinum-based drugs through the surface modification of heparin on mesoporous silica nanoparticles
    Ngoc-Hang Truong-Thi, Ngoc Hoi Nguyen, Dinh Tien Dung Nguyen, Tuan‐Ngan Tang, Thi Hiep Nguyen, Dai Hai Nguyen · 2023 · European Polymer Journal
  95. MSC-NPRA loop drives fatty acid oxidation to promote stemness and chemoresistance of gastric cancer
    Zetian Chen, Penghui Xu, Xinghong Wang, Ying Li, Jing Yang, Yiwen Xia, Sen Wang, Hongda Liu, Zekuan Xu, Zheng Li · 2023 · Cancer Letters
  96. A novel platinum complex of the histone deacetylase inhibitor belinostat: Rational design, development and in vitro cytotoxicity
    Parker, James P., Nimir, Hassan, Griffith, Darren M., Duff, Brian, Chubb, Anthony J., Brennan, Marian P., Morgan, Maria P., Egan, Denise A., Marmion, Celine J. · 2013 · Journal of Inorganic Biochemistry
  97. Synthetic induction of immunogenic cell death by genetic stimulation of endoplasmic reticulum stress
    Mickaël Michaud, Abdul Qader Sukkurwala, Federica Di Sano, Laurence Zitvogel, Oliver Kepp, Guido Kroemer · 2014 · OncoImmunology
  98. RUNX3 contributes to carboplatin resistance in epithelial ovarian cancer cells
    Samir H. Barghout, Nubia Zepeda, Krista Marie Vincent, Abul Kalam Azad, Zhihua Xu, Christine Yang, Helen L. Steed, Lynne-Marie M Postovit, Yangxin Fu · 2015 · Gynecologic Oncology
  99. Picoplatin pharmacokinetics and chemotherapy of non-small cell lung cancer
    Gerhard Hamilton, Ulrike Olszewski · 2013 · Expert Opinion on Drug Metabolism & Toxicology
  100. Targeting drug resistance in glioblastoma (Review)
    Jonathan H. Sherman, A Bobak, Tasneem A. Arsiwala, Paul R. Lockman, Sonikpreet Aulakh · 2024 · International Journal of Oncology